Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 329

1.

Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1.

Hsu EC, Rice MA, Bermudez A, Marques FJG, Aslan M, Liu S, Ghoochani A, Zhang CA, Chen YS, Zlitni A, Kumar S, Nolley R, Habte F, Shen M, Koul K, Peehl DM, Zoubeidi A, Gambhir SS, Kunder CA, Pitteri SJ, Brooks JD, Stoyanova T.

Proc Natl Acad Sci U S A. 2020 Jan 13. pii: 201905384. doi: 10.1073/pnas.1905384117. [Epub ahead of print]

2.

Identification of Diagnostic Metabolic Signatures in Clear Cell Renal Cell Carcinoma Using Mass Spectrometry Imaging.

Vijayalakshmi K, Shankar V, Bain RM, Nolley R, Sonn GA, Kao CS, Zhao H, Tibshirani R, Zare RN, Brooks JD.

Int J Cancer. 2019 Dec 21. doi: 10.1002/ijc.32843. [Epub ahead of print]

PMID:
31863456
3.

Association between maternal acetaminophen use and adverse birth outcomes in a pregnancy and birth cohort.

Arneja J, Hung RJ, Seeto RA, Knight JA, Hewko SL, Bocking A, Lye SJ, Brooks JD.

Pediatr Res. 2019 Dec 18. doi: 10.1038/s41390-019-0726-8. [Epub ahead of print]

PMID:
31852009
4.

miR-22 Regulates Invasion, Gene Expression and Predicts Overall Survival in Patients with Clear Cell Renal Cell Carcinoma.

Gong X, Zhao H, Saar M, Peehl DM, Brooks JD.

Kidney Cancer. 2019 Aug 7;3(2):119-132. doi: 10.3233/KCA-190051.

5.

Editorial Comment.

Brooks JD.

J Urol. 2020 Feb;203(2):350. doi: 10.1097/01.JU.0000612612.70338.13. Epub 2019 Nov 1. No abstract available.

PMID:
31674872
6.

African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study (PASS).

Schenk JM, Newcomb LF, Zheng Y, Faino AV, Zhu K, Nyame YA, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW.

J Urol. 2019 Oct 25:101097JU0000000000000621. doi: 10.1097/JU.0000000000000621. [Epub ahead of print]

PMID:
31651227
7.

S100A10 Is a Critical Mediator of GAS6/AXL-Induced Angiogenesis in Renal Cell Carcinoma.

Xiao Y, Zhao H, Tian L, Nolley R, Diep AN, Ernst A, Fuh KC, Miao YR, von Eyben R, Leppert JT, Brooks JD, Peehl DM, Giaccia AJ, Rankin EB.

Cancer Res. 2019 Nov 15;79(22):5758-5768. doi: 10.1158/0008-5472.CAN-19-1366. Epub 2019 Oct 4.

PMID:
31585940
8.

Association of a Pathway-Specific Genetic Risk Score With Risk of Radiation-Associated Contralateral Breast Cancer.

Watt GP, Reiner AS, Smith SA, Stram DO, Capanu M, Malone KE, Lynch CF, John EM, Knight JA, Mellemkjær L, Bernstein L, Brooks JD, Woods M, Liang X, Haile RW, Riaz N, Conti DV, Robson M, Duggan D, Boice JD Jr, Shore RE, Tischkowitz M, Orlow I, Thomas DC, Concannon P, Bernstein JL.

JAMA Netw Open. 2019 Sep 4;2(9):e1912259. doi: 10.1001/jamanetworkopen.2019.12259.

9.

Extracting Patient-Centered Outcomes from Clinical Notes in Electronic Health Records: Assessment of Urinary Incontinence After Radical Prostatectomy.

Gori D, Banerjee I, Chung BI, Ferrari M, Rucci P, Blayney DW, Brooks JD, Hernandez-Boussard T.

EGEMS (Wash DC). 2019 Aug 20;7(1):43. doi: 10.5334/egems.297.

10.

Simultaneous transrectal ultrasound and photoacoustic human prostate imaging.

Kothapalli SR, Sonn GA, Choe JW, Nikoozadeh A, Bhuyan A, Park KK, Cristman P, Fan R, Moini A, Lee BC, Wu J, Carver TE, Trivedi D, Shiiba L, Steinberg I, Huland DM, Rasmussen MF, Liao JC, Brooks JD, Khuri-Yakub PT, Gambhir SS.

Sci Transl Med. 2019 Aug 28;11(507). pii: eaav2169. doi: 10.1126/scitranslmed.aav2169.

PMID:
31462508
11.

Machine Learning Approaches for Extracting Stage from Pathology Reports in Prostate Cancer.

Lenain R, Seneviratne MG, Bozkurt S, Blayney DW, Brooks JD, Hernandez-Boussard T.

Stud Health Technol Inform. 2019 Aug 21;264:1522-1523. doi: 10.3233/SHTI190515.

PMID:
31438212
12.

Multiregion Quantification of Extracellular Signal-regulated Kinase Activity in Renal Cell Carcinoma.

Hoerner CR, Massoudi R, Metzner TJ, Stell L, O'Rourke JJ, Kong CS, Liliental JE, Brooks JD, Sabatti C, Leppert JT, Fan AC.

Eur Urol Oncol. 2018 Nov 19. pii: S2588-9311(18)30171-8. doi: 10.1016/j.euo.2018.09.011. [Epub ahead of print]

PMID:
31412000
13.

Improved detection of prostate cancer using a magneto-nanosensor assay for serum circulating autoantibodies.

Xu L, Lee JR, Hao S, Ling XB, Brooks JD, Wang SX, Gambhir SS.

PLoS One. 2019 Aug 12;14(8):e0221051. doi: 10.1371/journal.pone.0221051. eCollection 2019.

14.

Early detection of unilateral ureteral obstruction by desorption electrospray ionization mass spectrometry.

Banerjee S, Wong AC, Yan X, Wu B, Zhao H, Tibshirani RJ, Zare RN, Brooks JD.

Sci Rep. 2019 Jul 29;9(1):11007. doi: 10.1038/s41598-019-47396-x.

15.

Predictive value of AZGP1 following radical prostatectomy for prostate cancer: a cohort study and meta-analysis.

Kristensen G, Berg KD, Toft BG, Stroomberg HV, Nolley R, Brooks JD, Brasso K, Roder MA.

J Clin Pathol. 2019 Oct;72(10):696-704. doi: 10.1136/jclinpath-2019-205940. Epub 2019 Jul 22.

PMID:
31331953
16.

Is it possible to automatically assess pretreatment digital rectal examination documentation using natural language processing? A single-centre retrospective study.

Bozkurt S, Kan KM, Ferrari MK, Rubin DL, Blayney DW, Hernandez-Boussard T, Brooks JD.

BMJ Open. 2019 Jul 18;9(7):e027182. doi: 10.1136/bmjopen-2018-027182.

17.

PSA Testing Use and Prostate Cancer Diagnostic Stage After the 2012 U.S. Preventive Services Task Force Guideline Changes.

Magnani CJ, Li K, Seto T, McDonald KM, Blayney DW, Brooks JD, Hernandez-Boussard T.

J Natl Compr Canc Netw. 2019 Jul 1;17(7):795-803. doi: 10.6004/jnccn.2018.7274.

PMID:
31319390
18.

Outcomes of venous bypass combined with thoracic outlet decompression for treatment of upper extremity central venous occlusion.

Edwards JB, Brooks JD, Wooster MD, Fernandez B, Summers K, Illig KA.

J Vasc Surg Venous Lymphat Disord. 2019 Sep;7(5):660-664. doi: 10.1016/j.jvsv.2019.03.016. Epub 2019 Jun 5.

PMID:
31176658
19.

Applying the PRECISION approach in biopsy naïve and previously negative prostate biopsy patients.

Wang NN, Teslovich NC, Fan RE, Ghanouni P, Leppert JT, Brooks JD, Ahmadi S, Sonn GA.

Urol Oncol. 2019 Aug;37(8):530.e19-530.e24. doi: 10.1016/j.urolonc.2019.05.002. Epub 2019 May 29.

20.

Genomic analysis of benign prostatic hyperplasia implicates cellular re-landscaping in disease pathogenesis.

Middleton LW, Shen Z, Varma S, Pollack AS, Gong X, Zhu S, Zhu C, Foley JW, Vennam S, Sweeney RT, Tu K, Biscocho J, Eminaga O, Nolley R, Tibshirani R, Brooks JD, West RB, Pollack JR.

JCI Insight. 2019 May 16;5. pii: 129749. doi: 10.1172/jci.insight.129749.

21.

Weakly supervised natural language processing for assessing patient-centered outcome following prostate cancer treatment.

Banerjee I, Li K, Seneviratne M, Ferrari M, Seto T, Brooks JD, Rubin DL, Hernandez-Boussard T.

JAMIA Open. 2019 Apr;2(1):150-159. doi: 10.1093/jamiaopen/ooy057. Epub 2019 Jan 4.

22.

Comparison of orthogonal NLP methods for clinical phenotyping and assessment of bone scan utilization among prostate cancer patients.

Coquet J, Bozkurt S, Kan KM, Ferrari MK, Blayney DW, Brooks JD, Hernandez-Boussard T.

J Biomed Inform. 2019 Jun;94:103184. doi: 10.1016/j.jbi.2019.103184. Epub 2019 Apr 20.

PMID:
31014980
23.

Correction: Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the ω -3 polyunsaturated fatty acid docosahexaenoic acid.

Musiek ES, Brooks JD, Joo M, Brunoldi E, Porta A, Zanoni G, Vidari G, Blackwell TS, Montine TJ, Milne GL, McLaughlin B, Morrow JD.

J Biol Chem. 2019 Apr 19;294(16):6657. doi: 10.1074/jbc.AAC119.008639. No abstract available.

24.

Identifying Cases of Metastatic Prostate Cancer Using Machine Learning on Electronic Health Records.

Seneviratne MG, Banda JM, Brooks JD, Shah NH, Hernandez-Boussard TM.

AMIA Annu Symp Proc. 2018 Dec 5;2018:1498-1504. eCollection 2018.

25.

An Automated Feature Engineering for Digital Rectal Examination Documentation using Natural Language Processing.

Bozkurt S, Park JI, Kan KM, Ferrari M, Rubin DL, Brooks JD, Hernandez-Boussard T.

AMIA Annu Symp Proc. 2018 Dec 5;2018:288-294. eCollection 2018.

26.

Factors Associated With Unplanned Reoperation After Above-Knee Amputation.

Edwards JB, Wooster MD, Tran T, Armstrong PA, Moudgill N, Shames ML, Brooks JD.

JAMA Surg. 2019 May 1;154(5):461-462. doi: 10.1001/jamasurg.2018.5074. No abstract available.

PMID:
30725076
27.

Vasectomy and the risk of prostate cancer in a prospective US Cohort: Data from the NIH-AARP Diet and Health Study.

Davenport MT, Zhang CA, Leppert JT, Brooks JD, Eisenberg ML.

Andrology. 2019 Mar;7(2):178-183. doi: 10.1111/andr.12570. Epub 2019 Feb 3.

PMID:
30714352
28.

Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS).

Newcomb LF, Zheng Y, Faino AV, Bianchi-Frias D, Cooperberg MR, Brown MD, Brooks JD, Dash A, Fabrizio MD, Gleave ME, Liss M, Morgan TM, Thompson IM, Wagner AA, Carroll PR, Nelson PS, Lin DW.

Prostate Cancer Prostatic Dis. 2019 Sep;22(3):438-445. doi: 10.1038/s41391-018-0124-z. Epub 2019 Jan 21.

29.

Educational resources for vascular laboratory education in vascular surgery residencies and fellowships: Survey of Vascular Surgery Program Directors.

Tanious A, Brooks JD, Wang LJ, Shames ML, Armstrong PA, Conrad MF, Dawson DL.

J Vasc Surg. 2019 Jun;69(6):1918-1923. doi: 10.1016/j.jvs.2018.10.070. Epub 2019 Jan 6.

PMID:
30622008
30.

Performance of multiparametric MRI appears better when measured in patients who undergo radical prostatectomy.

Wang NN, Fan RE, Leppert JT, Ghanouni P, Kunder CA, Brooks JD, Chung BI, Sonn GA.

Res Rep Urol. 2018 Nov 22;10:233-235. doi: 10.2147/RRU.S178064. eCollection 2018.

31.

CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study.

Brooks JD, Comen EA, Reiner AS, Orlow I, Leong SF, Liang X, Mellemkjær L, Knight JA, Lynch CF, John EM, Bernstein L, Woods M, Doody DR; WECARE Study collaborative group, Malone KE, Bernstein JL.

Breast Cancer Res. 2018 Dec 10;20(1):149. doi: 10.1186/s13058-018-1083-y.

32.

Distribution of global health measures from routinely collected PROMIS surveys in patients with breast cancer or prostate cancer.

Seneviratne MG, Bozkurt S, Patel MI, Seto T, Brooks JD, Blayney DW, Kurian AW, Hernandez-Boussard T.

Cancer. 2019 Mar 15;125(6):943-951. doi: 10.1002/cncr.31895. Epub 2018 Dec 4.

PMID:
30512191
33.

Undertreatment of High-Risk Localized Prostate Cancer in the California Latino Population.

Lichtensztajn DY, Leppert JT, Brooks JD, Shah SA, Sieh W, Chung BI, Gomez SL, Cheng I.

J Natl Compr Canc Netw. 2018 Nov;16(11):1353-1360. doi: 10.6004/jnccn.2018.7060.

34.

Elevated urinary lipocalin-2, interleukin-6 and monocyte chemoattractant protein-1 levels in children with congenital ureteropelvic junction obstruction.

Yu L, Zhou L, Li Q, Li S, Luo X, Zhang C, Wu B, Brooks JD, Sun H.

J Pediatr Urol. 2019 Feb;15(1):44.e1-44.e7. doi: 10.1016/j.jpurol.2018.10.007. Epub 2018 Oct 17.

PMID:
30420258
35.

Utilization of Prostate Cancer Quality Metrics for Research and Quality Improvement: A Structured Review.

Gori D, Dulal R, Blayney DW, Brooks JD, Fantini MP, McDonald KM, Hernandez-Boussard T.

Jt Comm J Qual Patient Saf. 2019 Mar;45(3):217-226. doi: 10.1016/j.jcjq.2018.06.004. Epub 2018 Sep 18. Review.

PMID:
30236510
36.

Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI.

Sung JS, Corben AD, Brooks JD, Edelweiss M, Keating DM, Lin C, Morris EA, Patel P, Robson M, Woods M, Bernstein JL, Pike MC.

Breast Cancer Res Treat. 2018 Nov;172(2):487-496. doi: 10.1007/s10549-018-4916-6. Epub 2018 Aug 23.

37.

Architecture and Implementation of a Clinical Research Data Warehouse for Prostate Cancer.

Seneviratne MG, Seto T, Blayney DW, Brooks JD, Hernandez-Boussard T.

EGEMS (Wash DC). 2018 Jun 1;6(1):13. doi: 10.5334/egems.234.

38.

Continued 5α-Reductase Inhibitor Use after Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the PASS.

Kearns JT, Faino AV, Schenk JM, Newcomb LF, Brooks JD, Carroll PR, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner A, Zheng Y, Lin DW.

J Urol. 2019 Jan;201(1):106-111. doi: 10.1016/j.juro.2018.07.065.

PMID:
30076904
39.

Re: Brandon A. Mahal, David D. Yang, Natalie Q. Wang, et al. Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer. Eur Urol 2018;74:146-54.

Leppert JT, Brooks JD.

Eur Urol. 2018 Nov;74(5):e110-e111. doi: 10.1016/j.eururo.2018.06.044. Epub 2018 Jul 13. No abstract available.

PMID:
30017399
40.

Mining Electronic Health Records to Extract Patient-Centered Outcomes Following Prostate Cancer Treatment.

Hernandez-Boussard T, Kourdis PD, Seto T, Ferrari M, Blayney DW, Rubin D, Brooks JD.

AMIA Annu Symp Proc. 2018 Apr 16;2017:876-882. eCollection 2017.

41.

The Role of DNA Methylation in Renal Cell Carcinoma.

Lasseigne BN, Brooks JD.

Mol Diagn Ther. 2018 Aug;22(4):431-442. doi: 10.1007/s40291-018-0337-9. Review.

42.

Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts.

Helgstrand JT, Røder MA, Klemann N, Toft BG, Lichtensztajn DY, Brooks JD, Brasso K, Vainer B, Iversen P.

Cancer. 2018 Jul 15;124(14):2931-2938. doi: 10.1002/cncr.31384. Epub 2018 May 3.

43.

Multi-lectin Affinity Chromatography and Quantitative Proteomic Analysis Reveal Differential Glycoform Levels between Prostate Cancer and Benign Prostatic Hyperplasia Sera.

Totten SM, Adusumilli R, Kullolli M, Tanimoto C, Brooks JD, Mallick P, Pitteri SJ.

Sci Rep. 2018 Apr 25;8(1):6509. doi: 10.1038/s41598-018-24270-w.

44.

The Research Implications of Prostate Specific Antigen Registry Errors: Data from the Veterans Health Administration.

Guo DP, Thomas IC, Mittakanti HR, Shelton JB, Makarov DV, Skolarus TA, Cooperberg MR, Sonn GA, Chung BI, Brooks JD, Leppert JT.

J Urol. 2018 Sep;200(3):541-548. doi: 10.1016/j.juro.2018.03.127. Epub 2018 Apr 6.

PMID:
29630980
45.

Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study.

Reiner AS, Sisti J, John EM, Lynch CF, Brooks JD, Mellemkjær L, Boice JD, Knight JA, Concannon P, Capanu M, Tischkowitz M, Robson M, Liang X, Woods M, Conti DV, Duggan D, Shore R, Stram DO, Thomas DC, Malone KE, Bernstein L; WECARE Study Collaborative Group, Bernstein JL.

J Clin Oncol. 2018 May 20;36(15):1513-1520. doi: 10.1200/JCO.2017.77.3424. Epub 2018 Apr 5.

46.

The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study.

Knight JA, Blackmore KM, Fan J, Malone KE, John EM, Lynch CF, Vachon CM, Bernstein L, Brooks JD, Reiner AS, Liang X, Woods M; WECARE Study Collaborative Group, Bernstein JL.

Breast Cancer Res. 2018 Mar 22;20(1):23. doi: 10.1186/s13058-018-0948-4.

47.

MRI background parenchymal enhancement, breast density and serum hormones in postmenopausal women.

Brooks JD, Sung JS, Pike MC, Orlow I, Stanczyk FZ, Bernstein JL, Morris EA.

Int J Cancer. 2018 Aug 15;143(4):823-830. doi: 10.1002/ijc.31370. Epub 2018 Mar 25.

48.

Identification of transcripts associated with renal damage due to ureteral obstruction as candidate urinary biomarkers.

Wu B, Gong X, Kennedy WA, Brooks JD.

Am J Physiol Renal Physiol. 2018 Jul 1;315(1):F16-F26. doi: 10.1152/ajprenal.00382.2017. Epub 2018 Feb 28.

49.

Genetic Parameter Estimates for Metabolizing Two Common Pharmaceuticals in Swine.

Howard JT, Ashwell MS, Baynes RE, Brooks JD, Yeatts JL, Maltecca C.

Front Genet. 2018 Feb 13;9:40. doi: 10.3389/fgene.2018.00040. eCollection 2018.

50.

Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer.

Sahoo D, Wei W, Auman H, Hurtado-Coll A, Carroll PR, Fazli L, Gleave ME, Lin DW, Nelson PS, Simko J, Thompson IM, Leach RJ, Troyer DA, True LD, McKenney JK, Feng Z, Brooks JD.

Oncotarget. 2018 Jan 5;9(5):6550-6561. doi: 10.18632/oncotarget.23973. eCollection 2018 Jan 19.

Supplemental Content

Loading ...
Support Center